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ORIGINAL ARTICLE
The NADPH oxidase NOX4 represses epithelial to amoeboid
transition and efﬁcient tumour dissemination
E Crosas-Molist1,2, E Bertran1, I Rodriguez-Hernandez2, C Herraiz2,4, G Cantelli2, À Fabra1, V Sanz-Moreno2 and I Fabregat1,3
Epithelial to mesenchymal transition is a common event during tumour dissemination. However, direct epithelial to amoeboid
transition has not been characterized to date. Here we provide evidence that cells from hepatocellular carcinoma (HCC), a highly
metastatic cancer, undergo epithelial to amoeboid transition in physiological environments, such as organoids or three-
dimensional complex matrices. Furthermore, the NADPH oxidase NOX4 inhibits this transition and therefore suppresses efﬁcient
amoeboid bleb-based invasion. Moreover, NOX4 expression is associated with E-cadherin levels and inversely correlated with
invasive features. NOX4 is necessary to maintain parenchymal structures, increase cell–cell and cell-to-matrix adhesion, and impair
actomyosin contractility and amoeboid invasion. Importantly, NOX4 gene deletions are frequent in HCC patients, correlating with
higher tumour grade. Contrary to that observed in mesenchymal cell types, here NOX4 suppresses Rho and Cdc42 GTPase
expression and downstream actomyosin contractility. In HCC patients, NOX4 expression inversely correlates with RhoC and Cdc42
levels. Moreover, low expression of NOX4 combined with high expression of either RhoC or Cdc42 is associated with worse
prognosis. Therefore, loss of NOX4 increases actomyosin levels and favours an epithelial to amoeboid transition contributing to
tumour aggressiveness.
Oncogene advance online publication, 12 December 2016; doi:10.1038/onc.2016.454
INTRODUCTION
Metastatic dissemination is the main cause of cancer deaths. Cell
migration and invasion underlie the complex set of events that are
required for metastasis to succeed. Cancer cells can disseminate
from the primary tumour either as individual cells, using
amoeboid or mesenchymal type of movement, or as cell sheets,
strands and clusters using collective migration.1 Individual cell
migration appears to be required for blood borne metastasis.2
Different types of individual movement differ in their cell–matrix
adhesion requirements, a process that is regulated by integrins
and their engagement of Rho GTPase signalling. Rho GTPases are
key regulators of cell migration due to their actions on the
cytoskeleton. High levels of actomyosin contractility and lower
levels of adhesion are characteristic of rounded amoeboid form of
movement, in which blebs are used as functional protrusions.3,4
Actomyosin contractility in amoeboid migration can be regulated
either by Rho and downstream ROCK activity, or by Cdc42 through
PAKs,5–8 in both cases resulting in phosphorylation of MLC2 and
therefore activating myosin II.9 In contrast, elongated mesench-
ymal migrating cells use Rac-dependent actin polymerisation, and
higher levels of integrin-dependent adhesion.10–12 Intravital in vivo
imaging studies have revealed how amoeboid migration is the
fastest way of moving, being the preferred strategy used in the
invasive fronts of melanomas and breast cancers.11–14 This is due
to the lower adhesive requirements that allow actin cortex ﬂows.15
Furthermore, physical conﬁnement imposed by physiologically
relevant complex matrices favours amoeboid behaviour.14,16,17
Therefore, understanding if amoeboid strategies can be used by
other cancer types is crucial.
Hepatocellular carcinoma (HCC) is the most frequent liver tumour,
presenting a high frequency of relapse and metastasis.18,19 Molecular
markers are not used in diagnosis or determination of prognosis and
treatment for patients; indeed, studies now aim to identify molecular
mechanisms that allow the design of new biomarkers at earlier
stages and better predict their survival time and the adequacy of
treatment.19 Studies on HCC cell migration have been mainly
focused on the role of epithelial–mesenchymal transition (EMT) and
its relevance in the metastatic process.20 During EMT an epithelial cell
loses cell–cell junctions and acquires a mesenchymal-like phenotype,
which increases its migratory and invasive properties. This phenom-
enon takes place particularly during embryogenesis and cancer21
and is regulated by numerous signalling pathways,22 which ﬁnally
converge in the expression of transcription factors that regulate
EMT.23 Cancer cells undergoing EMT have lost E-cadherin junctions
and may move as individual cells. However, there is a lack of
knowledge regarding the types of movement that contribute to HCC
metastatic competence.
During cell migration, Rho GTPases, reactive oxygen species
(ROS) and cytoskeletal organisation appear to function as a
complex regulatory network; however, more work is needed to
fully elucidate the interactions between these factors and their
potential in vivo relevance.24 The NADPH oxidase (NOX) family has
emerged in the last years as an important source of ROS in signal
transduction.25,26 In the liver, NOX4 plays important roles
mediating transforming growth factor-beta (TGF-β) actions. In
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stellate cells, NOX4 is required for TGF-β-induced myoﬁbroblast
activation, contributing to the development of liver ﬁbrosis,26
which attracted interest in the development of NOX inhibitors that
could be used in the clinic to ameliorate this disease.27 However,
in hepatocytes and liver tumour cells, NOX4 mediates TGF-β-
induced mitochondrial-mediated apoptosis, through modulation
of the expression of the pro-apoptotic genes BIM and BMF,28
which contributes to its well-known tumour suppressor effects.
Therefore, inhibition of NOX4 in liver cells might lead to pro-
tumorigenic processes. In favour of this hypothesis, we recently
found that NOX4 plays a role in regulating liver cell proliferation
either under physiological conditions or during tumorigenesis.29
NOX4 silencing increases the tumorigenic potential of human HCC
cells in xenografts in mice, resulting in earlier onset of tumour
formation and increase in tumour size.29 Overall, results strongly
suggested that NOX4 plays a growth inhibitory role. However,
whether NOX4 could also regulate other cellular processes that
occur later in progression and that favour tumour metastasis, such
as migration and invasion, remains unknown.
In the current study, we have explored the role of NOX4 in
regulating HCC migration and invasion. We have found that NOX4
supports epithelial parenchymal structures and that NOX4 loss, a
common event in HCC, is accompanied by acquision of efﬁcient
amoeboid invasive behaviour.
RESULTS
NOX4 is important for maintaining epithelial parenchymal
structures
We have previously found that HCC patients express lower NOX4
protein levels when compared with healthy livers.29 Accordingly,
analysis of NOX4 expression in different human HCC cell lines
revealed important differences, from cells expressing high levels
until cells that lack it (Figures 1a and b). As EMT is an important
event in the acquisition of migratory abilities, we focused on EMT
characteristics that could be associated with NOX4 expression. We
analysed E-cadherin levels, both by immunoﬂuorescence and
western blot, and results showed that cells with high levels of
NOX4 expression maintain epithelial features, whereas cells with
low levels of NOX4 had lower levels of E-cadherin (Figures 1b and c).
To analyse the effects of silencing NOX4 in those HCC cells that
express high levels of NOX4, we performed stable transfections
with speciﬁc NOX4 short hairpin RNAs (shRNAs) in PLC/PRF/5 and
Huh7 cells (Supplementary Figure 1). Silencing of NOX4 correlated
with decreased intracellular ROS production in all the cases
(Supplementary Figure 2). PLC/PRF/5 displayed an epithelial
phenotype forming parenchymal structures; however, when
NOX4 was silenced the parenchymal phenotype was lost,
correlating with decreased E-cadherin expression and lower cell-
to-cell contact areas (Figures 1d–f). Decreased E-cadherin levels
were similarly observed in NOX4 knocked down Huh7 cells
(Figure 1f). When cells were cultured on a physiologically relevant
pliable matrix, such as collagen I,13,30 HCC cells that formed groups
were those expressing higher levels of NOX4 (Figures 1g and h).
Disruption of parenchymal structures was observed after NOX4
depletion (Figures 1i and j), resulting in groups containing fewer
cells when compared with control (Figure 1k). These results show
that NOX4 is necessary for maintaining an epithelial phenotype
and a parenchymal structure in HCC cells.
NOX4 is important for cell-to-matrix adhesion
Next, we explored if NOX4 is also involved in cell-to-matrix
adhesion. Analysis of Vinculin (Figure 2a) or phosphorylated Focal
Adhesion Kinase (pFAK) (Supplementary Figure 3A) by immuno-
ﬂuorescence revealed lower levels of expression and a different
distribution in NOX4-silenced cells, when compared with control
cells. Both the area occupied by focal adhesions and the focal
adhesion number per cell were signiﬁcantly diminished in NOX4-
silenced cells (Figures 2b and c; Supplementary Figures 3B and C).
Using a α/β-integrin-mediated cell adhesion array, we conﬁrmed
decrease in levels of different integrin proteins on the cell surface.
Signiﬁcant lower levels of α2-, α5- and αV-integrins, as well as the
complex α5β1-integrin, were observed when NOX4 expression
was attenuated (Figure 2d; Supplementary Figure 4). These
changes in focal adhesions and integrin levels were translated
into a decrease in cell-to-matrix adhesion when NOX4 expression
was lost, which was monitored in real-time using xCELLigence
system (Acea Biosciences, San Diego, CA, USA) on cell culture
plates (Figure 2e). These results suggest that NOX4 is also
important for cell adhesion in HCC cells.
NOX4 suppresses migratory/invasive potential
We next analysed the migratory capacity of human HCC cells
using wound-healing and chemotaxis assays. High levels of NOX4
were associated with lower migratory potential (Supplementary
Figures 5A and B). Moreover, NOX4 silencing resulted in increased
cell migration using both a wound-healing assay and real-time
monitoring of cell migration either by xCELLigence system
(Supplementary Figures 5C and D) or by time-lapse video
microscopy analysis on a three-dimensional (3D) pliable matrix
(Figures 3a–d; Supplementary Videos 1-3). To assess the invasive
capacity of cells, we used an assay that measures individual cell
invasion in three dimensions.12,13 We used two different matrices,
collagen I and collagen I/matrigel mixture to recapitulate matrix
heterogeneity found in HCC lesions. Cells expressing low levels of
NOX4 (HLF and SNU449) were the most invasive ones (Figure 3e).
NOX4 loss increased the invasion potential of Huh7 and PLC/PRF/5
cells (Figure 3f). We further validated the relevance of NOX4 in
HCC cell migration and invasion studying the behaviour of HCC
cells cultured as spheroids embedded in collagen I. This assay
measures proliferation and invasion over time (invasive growth).31
In a period of 4 days, cells with high levels of NOX4 showed lower
invasive growth capacity (Figure 3g). Importantly, NOX4 silencing
in Huh7 and PLC/PRF/5 cells increased their invasive growth
capacity (Figure 3h). Furthermore, we found that 23% of HCC
patients presented NOX4 deletion, when NOX4 DNA copy number
alterations were analysed using The Cancer Genome Atlas
Figure 1. NOX4 regulates cell–cell adhesion in HCC cells. (a) NOX4 expression levels by quantitative PCR. Data represent the mean± s.e.m.
(N= 4). (b) NOX4 and E-cadherin protein levels by western blot. β-actin was used as loading control. A representative experiment is shown
(N= 3). Quantiﬁcation normalized by loading control is shown under each blot. (c) Immunoﬂuorescence of E-cadherin (green) and DAPI (blue;
scale bar, 50 μm). (d) Representative bright-ﬁeld images of cells cultured at basal conditions on top of plastic (left). Cell–cell contact imaging
by immunoﬂuorescence of E-cadherin (green) and ZO-1 (green); DAPI (blue; N= 3; scale bar, 50 μm; right). (e) Analysis of CDH1 (E-cadherin)
expression in PLC/PRF/5 cells by quantitative PCR. Data are mean± s.e.m. (N= 4). (f) E-cadherin protein levels by western blot. β-actin was used
as loading control. A representative experiment is shown (N= 3). (g) Representative bright-ﬁeld images of human HCC cells cultured on top of
a bovine collagen I matrix (scale bar, 50 μm). (h) Quantiﬁcation of the percentage of individual cells in each case. (i) Representative bright-ﬁeld
images of cells on top of a bovine collagen I matrix when NOX4 expression is silenced (scale bar, 50 μm). (j) Quantiﬁcation of the percentage
of individual cells in each case. (k) Number of cells per group. In (h, j and k) data are mean± s.e.m. (N= 4). See also Supplementary Figures 1
and 2.
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Figure 2. Loss of NOX4 disrupts cell–matrix adhesion in HCC cells. (a) Immunoﬂuorescence of Vinculin (green) and DAPI (blue; N= 3, 5
pictures/experiment; scale bar, 20 μm). (b and c) Vinculin image processing using ImageJ software: analysis of the area occupied by focal
adhesions per cell (b), and quantiﬁcation of the number of focal adhesions per cell (c). (d) Analysis of cell surface integrins using a α/β-
Integrin-mediated cell adhesion array (Millipore). Selection of those integrins that presented signiﬁcant changes in PLC/PRF/5 shNOX4(#1)
cells (N= 3). See the whole panel of integrins analysed in Supplementary Figure 4. (f) Real-time adhesion assay (xCELLigence system). Data
are expressed as percentage versus control (unspeciﬁc shRNA-transfected) cells (N= 3). In (b–e) data are mean± s.e.m. See also
Supplementary Figure 3.
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Figure 3. For Caption see next page.
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database (http://cancergenome.nih.gov/) (n= 249 patients). Inter-
estingly, NOX4 deletions were more frequently found in late
stages of liver tumorigenesis (32% of patients in grade 3/4 versus
17% of patients in grade 1/2; Figure 3i).
We had previously reported a tumour-suppressive role for NOX4
via negative regulation of proliferation.29 With all these new data,
we prove that NOX4 not only suppresses tumour growth, but also
tumour invasion in HCC. Therefore, NOX4 may act as a tumour
suppressor at different levels.
NOX4 suppresses actomyosin contractility and amoeboid features
Actomyosin contractility is a major driver of invasion in 3D complex
environments32 and higher levels of actomyosin contractility have
been associated with lower levels of adhesion.16,17 As actomyosin
driven bleb-based migration has been shown recently to offer an
advantage in many relevant physiological scenarios,1,14,16,17,33,34 we
ﬁrst investigated if HCC cell lines can display amoeboid-blebbing
behaviour, as this has not been described to date. We could observe
bleb-like structures in some of the cell lines in our panel and this
associated with increased levels of myosin light chain 2 (MLC2)
phosphorylation. Note that we could not observe blebs when cells
were part of parenchymal structures. More importantly, bleb
formation and MLC2 phosphorylation levels were inversely asso-
ciated with NOX4 expression (Figures 4a–c). In addition, NOX4 loss
increased the percentage of cells with blebs and the levels of MLC2
phosphorylation (Figures 4d–g). Interestingly, after 3D imaging of
NOX4-silenced invading cells, we could observe that they were
rounded (Figure 4h). Similarly, amoeboid invasive behaviour was
observed when imaging the most invasive cell line in our panel,
SNU449 (Figure 4h). Therefore, these data show that NOX4, through
its role as a negative regulator of actomyosin contractility, could
regulate a contractile amoeboid phenotype and the invasive capacity
of HCC cells.
Overexpression of NOX4 suppresses actomyosin contractility and
invasion
So far our data show that NOX4 plays a relevant role in
maintaining epithelial and non-invasive features in HCC cells.
Thus, we wondered whether re-expression of NOX4 could impact
migratory and invasive properties. NOX4 overexpression in highly
invasive SNU449 cells (reaching similar levels to those found in
Huh7; Figure 5a) promoted the appearance of parenchymal
structures, re-expression of important proteins for cell–cell
interactions, such as ZO-1, and an increase in the number of
focal adhesion complexes (Figure 5b). Furthermore, NOX4 over-
expression induced a decrease in actomyosin contractility levels
(Figures 5c–e), a decrease on the percentage of individual cells
(Figure 5f), and reduced migratory (Figures 5g–i; Supplementary
Videos 4 and 5) and invasive potential (Figure 5j). Moreover,
cells cultured as spheroids into collagen I suffered a marked
impairment on invasive growth when NOX4 was overexpressed
(Figures 5k and l). All these data indicate that the sole
overexpression of NOX4 is enough for maintaining parenchymal
structures, increasing cell–substrate adhesion and suppressing
actomyosin contractility and invasive behaviour in HCC cells.
NOX4 regulates Rho GTPase expression
Rho GTPases are crucial regulators of the cytoskeleton during cell
migration and invasion.32 In order to understand how NOX4 is
suppressing contractility and the invasive capacity of HCC cells, we
analysed expression levels of different Rho GTPases that have
been reported to be crucial for sustaining bleb-based migration
and actomyosin contractility.6,7,11 We found higher messenger
RNA (mRNA; Figure 6a) and protein levels (Figure 6b) of RhoA,
RhoC and Cdc42 in cells with low NOX4 expression. In accordance,
NOX4 loss in Huh7 and PLC/PRF/5 cells increased the levels of
RhoA, RhoC and Cdc42 (Figures 6c and d) and conversely,
overexpression of NOX4 in SNU449 increased their levels
(Figure 6d). Furthermore, using publicly available data from gene
expression analysis (Gene Expression Omnibus, GEO), we observed
a signiﬁcant inverse correlation between NOX4 and Rho GTPases
expression (RhoC, Cdc42), as well as MLC2 (MYL9) expression
(Figure 6e). Indeed, there is a signiﬁcant increase in RhoC, Cdc42
and MYL9 expression levels in metastasis versus primary tumours
(Figure 6f), indicating that drivers of actomyosin contractility are
selected during HCC metastatic dissemination. Moreover, patients
with low expression of NOX4 and high expression of either RhoC
or Cdc42 had a signiﬁcantly worse prognosis compared with
patients that presented high expression of NOX4 and low
expression of RhoC or Cdc42 (n= 249 patients; Figure 6g). These
results suggest that invasive and metastatic behaviour in HCC
could be in part due to the regulation of Rho GTPase and MLC2
expression. These are all events suppressed by NOX4; therefore
this is a mechanism by which loss of NOX4 could contribute to the
progression of invasive HCCs.
DISCUSSION
Metastasis is a complex cascade of events, including abnormal
migration and invasion of cancer cells. EMT has been described as
a common step during metastatic dissemination of epithelial
cancers.21,35 Less is known about epithelial cancers transitioning
towards amoeboid behaviour. Here we provide evidence that
amoeboid invasion is, indeed, an efﬁcient strategy used by HCC
cells in physiologically relevant 3D environments. HCC is a poor
prognosis tumour, presenting a high frequency of relapse and
metastasis.18 In spite of recent advances in pharmacological
treatments, HCC patient survival remains low.36 One major
hallmark of an aggressive solitary HCC is its ability to migrate
and invade, which increases the number of intrahepatic nodules
(decreasing the transplantation possibilities), as well as its capacity
to metastasize to other organs. Thus, a better knowledge about
the mechanisms that regulate these processes may promote the
development of effective approaches to reduce HCC mortality.
Our work describes for the ﬁrst time that NOX4 inhibits epithelial
to amoeboid transition in HCC cells, maintains parenchymal
structures, increases cell-to-matrix adhesion and inhibits actomyo-
sin contractility through suppressing RhoC and Cdc42 GTPase
expression (Figure 7a). Indeed, loss of NOX4 could contribute to
HCC aggressive behaviour (Figure 7b).
The ﬁrst NOX described was the respiratory burst NADPH
oxidase complex, whose catalytic subunit is now known as NOX2.
The other family members have been cloned and studied in the
Figure 3. NOX4 suppresses the migratory/invasive potential of HCC cells. (a) Manual tracking of NOX4-silenced cells moving on a thick layer of
collagen I/matrigel. Quantiﬁcation of speed (b), distance (c) and directionality (d) of individual migrating cells. Data are expressed as mean±
s.e.m. (20–30cells per condition). See also Supplementary Videos 1-3. Quantiﬁcation of 3D invasion into a matrix of bovine collagen I (left) and
collagen I/matrigel mix (1:1; right) of different human HCC cell lines (e) and of NOX4 knocked down Huh7 and PLC/PRF/5 cells (f). Data are
expressed as fold increase versus Huh7 cells or shControl and are mean± s.e.m. (N= 3–5). (g) Invasive growth analysed embedding cells as
spheroids in a bovine collagen I matrix. Representative images at day 0 and 4 (scale bar, 100 μm). (h) Representative images and quantiﬁcation
of the increase in area of the spheroids from control (shControl) and NOX4-silenced (shNOX4) cells between day 0 and 4 after embedding
them into collagen (scale bar, 100 μm). (i) Percentage of HCC patients showing NOX4 deletion (23%) from the The Cancer Genome Atlas
database (N= 249). Proportion of HCC patients in tumour grade 1/2 (17%; left) and tumour grade 3/4 (32%; right) showing NOX4 deletion.
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Figure 4. NOX4 suppresses actomyosin contractility in HCC cells. In all experiments cells were cultured on top of a bovine collagen I matrix.
(a and d) Percentage of cells with blebs. (b and e) quantiﬁcation of phosphorylated MLC2 (pMLC2) immunostaining intensity per cell surface.
(c and f) Representative confocal images of pMLC2 (green), F-actin (red) and DAPI (blue) staining (N= 4; scale bar, 20 μm, square with a higher
magniﬁcation is shown for better visualisation). White arrows indicate blebs. Data in (a, b, d and e) are mean± s.e.m. (N= 4, at least ﬁve
pictures per experiment). (g) Phosphorylated and total MLC2 protein levels. GAPDH was used as loading control. A representative experiment
is shown (N= 3). (h) 3D imaging of PLC/PRF/5 (shControl and shNOX4) and SNU449 cells invading a collagen I/matrigel mix (1:1) matrix. Higher
magniﬁcation is shown for better visualization. Black arrow indicates direction of invasion.
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past 15 years.37 The functional analysis of the isoenzyme NOX4
revealed unique characteristics compared with other NADPH
oxidases.38 NOX4 associates with their regulators (p22phox or
Poldip2) in intracellular membranes, where the superoxide anion
is rapidly converted to H2O2. Neither any of the known cytosolic
oxidase proteins nor the GTPase Rac are required for its activity,
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which appears to be regulated mainly at the transcriptional
level.38–40 Role of NOX4 in tumour progression is controversial and
recent studies propose a role for NOX4 in supporting tumour
migration.41,42 However, although most of these studies were
performed in two-dimensional migration systems, we have
analysed the role of NOX4 in 3D systems that recapitulate
interstitial tissue surrounding tumours, where we previously found
that amoeboid migration is particularly efﬁcient. Furthermore, it is
worthy to note that NOX4 strongly mediates apoptosis and
senescence in HCC cells,43,44 as well as regulates homocysteine
metabolism, which impacts on hepatic glutathione levels.45
Altogether suggest that NOX4 could have liver-speciﬁc functions,
and its role may differ from other tumours, where it induces
migration and cell survival.41,42,46,47
Different data in the literature propose that NOX generated
ROS, particularly those derived from NOX1, NOX2 and NOX4, are
important regulators of the actin cytoskeleton and cytoskeleton-
supported cell functions.48 Molecular mechanisms are not fully
understood, although NOX4 may regulate, in a redox-dependent
manner, integrins function.49 In vascular smooth muscle cells,
NOX4 is required for focal adhesion formation and adhesion
strength50 and for the activation of cytoskeleton regulators.51
However, one of the most relevant ﬁnding of our work is the role
of NOX4 in regulating actomyosin contractility and Rho GTPases
gene expression. Expression of NOX4 in different human HCC cell
lines and in HCC patients inversely correlated with their levels of
RhoA, RhoC and Cdc42 both at mRNA and protein levels.
Furthermore, NOX4 knockdown increased RhoC and Cdc42
transcript levels, and RhoA, RhoC and Cdc42 protein levels. Many
Rho GTPases seem to be regulated at their expression and not just
by their activation status. Indeed, RhoA transcription is orche-
strated by the Myc/Skp2/Miz1/p300 transcription complex.52
Interestingly, it has been described that upregulation of NOX4 in
HCC cells is coincident with c-Myc downregulation,43 which would
justify its capacity to inhibit Rho GTPases expression. The role of
NOX4 on suppressing Rho GTPase expression and actomyosin
contractility further reinforces its potential as a suppressor of liver
tumour metastasis, as we show here that a signiﬁcant increase in
RhoC, Cdc42 and MLC2 expression levels is found in metastasis,
when compared with primary liver tumours. Moreover, using
publicly available data (The Cancer Genome Atlas) here we show
that low expression of NOX4 combined with high expression of
either RhoC or Cdc42 is associated with worse prognosis in HCC.
Interestingly, it has been recently reported that low NOX4
expression is an independent predictor of both shorter relapse-
free survival and shorter overall survival by using immunohisto-
chemistry in tumour tissue from 227 HCC patients.53
ROS-mediated signalling has recently emerged as playing
relevant suppressor actions, opposing to previous established
ideas pointing ROS as mediators of tumour progression and
antioxidants as anti-tumorigenic agents. Indeed, it has been
described that antioxidants, such N-acetyl-cysteine or Trolox,
increased the activation of RhoA and blocking RhoA signalling was
enough to abolish antioxidant-induced cell migration and in vivo
metastasis formation.54,55 Furthermore, we have recently
described how, in melanoma, RhoA activation and actomyosin
levels are suppressed by ARHGAP5, a Rho GTPase-activating
protein controlled by ROS.13 On the other hand, silencing of Nrf2,
a master transcriptional activator of genes encoding enzymes that
protect from oxidative stress, inhibits the ability of HCC cells to
grow in soft agar and to form tumours.56 Activating mutations of
Nrf2 occur at very early stages of the carcinogenic process, which
suggests that the activation of Nrf2 pathway is mandatory for HCC
progression.56
Our model ﬁts with these last results, proposing that the
expression of a gene involved in ROS-mediated signalling would
be a suppressor factor in HCC. However, further analyses are
needed to prove that the effects observed manipulating NOX4
expression are due to changes induced in ROS levels. Never-
theless, we show that NOX4 gene is deleted and/or expression
downregulated in a signiﬁcant percentage of HCC patients. Our
data strongly supports that NOX4 suppresses liver tumour
migration and invasion, which will need to be under consideration
when using speciﬁc drugs to inhibit NOX4 in liver diseases. Finally,
our work also adds HCC to the list of aggressive cancers that can
engage into amoeboid dissemination strategies. Further work is
needed to elucidate how many epithelial cancers can directly
undergo epithelial to amoeboid transitions. Importantly, NOX4
could repress these processes in other epithelial tumours, and act
as general metastasis suppressor.
MATERIALS AND METHODS
Cell models
Hep3B and PLC/PRF/5 cell lines were from the European Collection of Cell
Cultures (ECACC, Porton Down, Salisbury, Wiltshire, UK). Huh7 and HLF cells
(kindly provided by Dr Perales, University of Barcelona, Spain and Dr Giannelli,
University of Bari, Italy, respectively) were from the Japanese Collection of
Research Bioresources (JCRB Cell Bank, Ibaraki City, Osaka, Japan). SNU449
were from the American Tissue Culture Collection (ATCC, Manassas, VA, USA).
Hep3B cells were grown in MEM medium supplemented with non-essential
amino acids, SNU449 and HLF in RPMI medium, and Huh7, PLC/PRF/5 in
DMEM medium, supplemented with 10% fetal bovine serum (FBS), in a
humidiﬁed atmosphere at 37 °C, 5% CO2. Cell lines were never used in the
laboratory for longer than 3 months after receipt or resuscitation.
Cell culture on thick layers of collagen I
Fibrillar bovine collagen I (5005; PureCol, Advanced BioMatrix, San Diego,
CA, USA) was prepared at 1.7 mg/ml in DMEM according to the
manufacturer’s protocol. After polymerisation (4 h–37 °C, 10%CO2) cells
were seeded on top in medium containing 10% FBS and imaged after 24 h
in culture.
Knockdown assays
Huh7 and PLC/PRF/5 cell lines were stable silenced for NOX4 using four
different shRNA plasmids (either alone or in combination) as described (see
Supplementary Table I for shRNA sequences).29 Best-silenced clones were
chosen and at least two different shRNA or combinations were used in
each cell line.
Figure 5. Overexpression of NOX4 in SNU449 cells switches to a parenchymal phenotype, and suppresses actomyosin contractility and
invasive behaviour. (a) NOX4 mRNA (up) and protein (down) levels in SNU449 cells overexpressing NOX4 (+NOX4) and in Huh7 cells. Beta-actin
used as a loading control. (b) ZO-1 (green) and Vinculin (green) immunoﬂuorescence. DAPI (blue) to detect nuclei (N= 3; scale bar, 50 μm).
(c) Representative confocal images of immunostaining of pMLC2 and F-actin of HCC cells cultured on top of bovine collagen I matrix (N= 3;
scale bar, 50 μm). (d) Phosphorylated and total MLC2 protein levels. GAPDH was used as loading control. A representative experiment is
shown (N= 3). (e) Quantiﬁcation of pMLC2 immunostaining intensity per cell surface. (f) Quantiﬁcation of the percentage of individual cells
cultured on top of a collagen I matrix. (g) Manual tracking of SNU449 cells moving on a thick layer of collagen I/matrigel. Quantiﬁcation of
speed (h) and distance (i) of individual migrating cells. Data are mean± s.e.m. (20–30cells per condition). (j) Quantiﬁcation of 3D invasion into
a bovine collagen I matrix. (k) Representative images of spheroids from control and NOX4 overexpressing cells at day 0 and 2 after embedding
them into collagen I (scale bar, 100 μm). (l) Quantiﬁcation of the increase in area of the spheroids between day 0 and 2. Data in (a, c, f, j and l)
are mean± s.e.m. (N= 3).
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Overexpression assays
Lentiviral vector containing the human NOX4 sequence (NM_016931) was
obtained from GE Healthcare (Little Chalfont, UK; OHS5898–219582330).
Lentiviral supernatants were produced as previously described57 and used
to infect SNU449 cells, which were then selected with 10 μg/ml blasticidin
(from InvivoGen, Toulouse, France). The empty LentiORF-RFP-positive
control (OHS5898) was used as a control.
Analysis of gene expression
RNeasy Mini Kit (Qiagen, Valencia, CA, USA) was used for total RNA. Reverse
transcription was carried out with random primers using High Capacity
RNA to cDNA Master Mix Kit (Applied Biosystems, Foster City, CA, USA)
following manufacturer’s instructions. Expression levels were determined
in a LightCycler 480 Real Time PCR System, using the LightCycler 480 SYBR
Green I Master Mix (Roche Applied Science, Basel, Switzerland). See
Supplementary Table II for primers sequences.
Immunoblotting
Cells were lysed in RIPA lysis buffer 1 h at 4 °C. Western blotting
was carried out as described previously.29 For Rho GTPases expression,
cells were lysed in Laemmli sample buffer and sonicated 15 s before
centrifugation.13 Antibodies used are summarized in Supplementary
Table III.
Immunoﬂuorescence, confocal microscopy and image
quantiﬁcation
Epiﬂuorescence microscopy studies were performed as described previously.29
ImageJ software (National Institutes of Health, Bethesda, MD, USA) was used to
analyse the number, area and distribution of focal adhesions per cell from
pFAK immunostaining TIFF images. DAPI staining was used to elucidate the
number of cells.
For the immunostaining of cells seeded on top of a thick collagen I
matrix, cells were ﬁxed with paraformaldehyde and immunostained for
rabbit anti-phospho-MLC2 (Ser19, Cell Signaling Technology, Danvers, MA,
USA) and Alexa Fluor 546-phalloidin (Life Technologies Ltd, Paisley, UK) for
F-actin detection as described.13 For imaging, collagen gels were
transferred to glass-bottomed dishes and visualized on a Zeiss LSM 510
Meta confocal microscope (Carl Zeiss, Cambridge, UK) with C-Apochromat
× 40/1.2 numerical aperture (water) and Zen software (Carl Zeiss). Confocal
Z-slice images were analysed using ImageJ software. Phospho-MLC2
ﬂuorescence signal was quantiﬁed calculating the pixel intensity in single
cells relative to the cell area, determined using F-actin staining, using Fiji
open source software (National Institutes of Health).
Figure 7. NOX4 suppresses amoeboid invasion in HCC. (a) NOX4 maintains epithelial parenchymal structures in non-invasive HCC. Loss of
NOX4 promotes disruption of cell–cell and cell–substrate adhesion and increased RhoC and Cdc42 GTPases expression, favouring amoeboid
invasion. (b) HCC aggressiveness is promoted through epithelial to amoeboid transition upon NOX4 loss.
Figure 6. NOX4 suppresses the actomyosin regulators RhoA/C and Cdc42. (a and c) RhoA, RhoC and Cdc42 GTPases mRNA expression levels
analysed by quantitative PCR. Data represents the mean± s.e.m. (N= 4). (b and d) Representative western blot of RhoA, RhoC and Cdc42
GTPases. GAPDH was used as loading controls (N= 3–5). Quantiﬁcation normalized by loading control is shown under each blot. (e) Scatter
plots of NOX4, RhoC, Cdc42 and MYL9 (MLC2) expression correlation analysis using normalized mRNA expression data from GEO data sets
(accession number GSE40367). (f) NOX4, RhoC, Cdc42 and MYL9 (MLC2) expression levels comparing primary tumour versus metastasis using
same data set as in e. (g) Kaplan–Meier estimates of 5 years survival in The Cancer Genome Atlas HCC patients according to NOX4 expression
combined with RhoC and Cdc42 expression.
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Migration and invasion assays
Cell motility was examined by different methods: (i) transwell migration
assay,4 (ii) wound-healing assay58 and (iii) real-time migration assay
through the xCELLigence System (Acea Biosciences),58 and time-lapse
microscopy and cell tracking of cells seeded on top of a thick layer of
collagen I/matrigel.13 Spheroid cell culture was performed using the
hanging drop method, as described previously by Del Duca et al.59 Once
formed, spheroids were collected and resuspended in a collagen I solution
(1.7 mg/ml in DMEM). 10% FBS-containing media was added on top (day 0)
and phase contrast pictures were taken. For invasive growth quantiﬁcation,
increase on the area occupied by the spheroids between day 0 and 4 was
calculated using ImageJ software. For 3D invasion assays,13 cells were
resuspended in serum-free bovine collagen I solution at 2.3 mg/ml or in a
solution of serum-free bovine collagen I/matrigel (Corning, New York, NY,
USA) in a 1:1 proportion, to a ﬁnal concentration of 14 000 cells per 100 μl
of matrix and spun down, in a 96-well plate. After the matrix was
polymerized, 10% FBS-containing media was added on top of the gel. The
3D invasion index was calculated as number of invading cells at 50 μm
divided by the number of cells at the bottom. For 3D imaging of invading
cells, cells were stained with Alexa Fluor 546-phalloidin (Life Technologies
Ltd) and sequential Z sections were obtained using a Zeiss 710 confocal
microscope. 3D reconstructions of invaded cells were made using Zen
software.
Adhesion assay
Real-time cell adhesion was examined using the xCELLigence System
(Acea Biosciences). Overall 1.25 × 104 cells per well were seeded onto an
E-plate-VIEW 16 (Acea Biosciences), which features microelectronic sensors
integrated on the bottom of the plate. Continuous values were
represented as cell index, a dimensionless parameter reﬂecting a relative
change in measured electrical impedance, and quantiﬁed as a slope (per
hour) of the ﬁrst 3 h.
Integrin array
The α/β-Integrin-Mediated Cell Adhesion Array Combo Kit (ECM532, Merck
Millipore, Billerica, MA, USA) was used according to the manufacturer’s
instructions. Each well containing mouse anti-alpha or anti-beta integrin
received 100 μl containing 1.5 × 105 cells, as did the bovine serum
albumin-coated negative control wells. The plate was incubated for 2 h
at 37 °C in 5% CO2 and washed with assay buffer. Cells were then stained
with a Cell Stain Solution (provided in kit), incubated for 5 min and washed
with dH2O. Extraction buffer (100 μl) was added to each well and left to
shake for 5–10 min. Fluorescence was measured in Microplate Fluores-
cence Reader Fluostar optima (BMG Labtech GmbH, Ortenberg, Germany).
Analysis of gene expression from human databases
From public database GEO (Gene Expression Omnibus, accession number
GSE40367) we analysed expression of NOX4, RhoC, Cdc42 and MYL9 (MLC2)
comparing HCC primary tumours and metastasis. Data were normalized
using Gene Pattern (http://www.broadinstitute.org/cancer/software/gene
pattern/).
From The Cancer Genome Atlas database (http://cancergenome.nih.gov/),
we extracted gene expression data of 249 HCC patients to analyse NOX4,
RhoC and Cdc42 expression in HCC outcome. Only patients whose tumour
sample contained o15% of stroma were selected to avoid interference, as
NOX4 is highly expressed in surrounding non tumoral tissue. We also
extracted data concerning NOX4 DNA copy number alterations from the
same patients. Normalized mRNA expression data and z-scores for mRNA
expression data and copy number alterations from GISTIC were down-
loaded from cBioportal60,61 and analysed as described below.
Statistical analyses
Two-sided Student’s t-test versus control (unspeciﬁc shRNA-transfected)
cells was used to generate P-values when only two groups were compared.
Two-sided one-way analysis of variance with Dunnett’s post hoc test versus
Huh7 cells (when cell lines were compared) or versus shControl (when
silencing shRNA were compared) was used to generate P-values (*Po0.05,
**Po0.01 and ***Po0.001). Statistical analyses were performed using
GraphPad Prism software (GraphPad, San Diego, California, USA). Data
were represented as mean± s.e.m. In general, experiments were carried
out at least three independent times with two to three technical replicates.
Pearson χ2 was used to determine P-values when comparing NOX4 DNA
copy number events and tumour grade.
For survival analysis, The Cancer Genome Atlas expression data were
categorized using a z-score cutoff of 0. Kaplan–Meier method using the
log-rank test was used to estimate survival curves. Pearson χ2 and survival
analysis were performed using SPSS (IBM, North Harbour, Portsmouth, UK).
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